A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain

NCT01439100 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease With Severe Pain

Interventions

DRUG: Oxycodone/Naloxone Prolonged Release tablets
DRUG: Placebo

Sponsor

Mundipharma Research GmbH & Co KG